Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy

NCT03595813 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
135
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Institut Paoli-Calmettes

Collaborators